KOD
Kodiak Sciences Inc - Common Stock (KOD)
$71
About Kodiak Sciences Inc - Common Stock (KOD)
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Details
Daily high
$32.82
Daily low
$31.54
Price at open
--
52 Week High
$47.84
52 Week Low
$9.80
Market cap
2.1B
Dividend yield
-
Volume
2,103
Avg. volume
678,694
P/E ratio
-7.80
Kodiak Sciences Inc - Common Stock News
Details
Daily high
$32.82
Daily low
$31.54
Price at open
--
52 Week High
$47.84
52 Week Low
$9.80
Market cap
2.1B
Dividend yield
-
Volume
2,103
Avg. volume
678,694
P/E ratio
-7.80